Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
This multi-receptor activation enables: GLP-1R activation enhances glucose-dependent insulin secretion and reduces appetite through hypothalamic signaling GIPR activation (highest potency: EC50 0.0643 nM) promotes insulin secretion and modulates lipid metabolism GCGR activation (EC50 5.79 nM) increases energy expenditure and promotes hepatic fat oxidation Combined receptor engagement produces dose-dependent reductions in body weight and improvements in glycemic control Research demonstrates that GLP3s balanced activation across three receptors produces superior metabolic effects compared to single or dual agonists, with phase 2 trials showing up to 24.2% weight reduction in 48 weeks[2]
ADP/t: Rate of ADP phosphorylation
CJC-1295 (no DAC) is often studied in combination with other secretagogues like Ipamorelin for potential synergistic effects
This article explores evidence-based B12 dosing for neuropathic pain, mechanisms of nerve repair, deficiency recognition, and when to seek NHS medical assessment for proper diagnosis and monitoring
US$ 20.39
US$ 24.66
US$ 28.03
